Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.21.2
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,168,492 815,311 1,168,492 815,311
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 118,388 173,041 118,388 173,041
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 1,050,104 642,270 1,050,104 642,270